These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sources of variability in clinical trials of new drugs for epilepsy. Leppik IE Epilepsy Res Suppl; 1993; 10():157-66. PubMed ID: 8251091 [No Abstract] [Full Text] [Related]
4. European investigational antiepilepsy drug trials. Sussman NM Epilepsy Res Suppl; 1993; 10():149-55. PubMed ID: 8251090 [No Abstract] [Full Text] [Related]
5. Study population selection. Treiman DM Epilepsy Res Suppl; 1993; 10():125-35. PubMed ID: 8251088 [No Abstract] [Full Text] [Related]
6. External influences on protocol design. Spilker B Epilepsy Res Suppl; 1993; 10():115-24. PubMed ID: 8251087 [No Abstract] [Full Text] [Related]
7. Obstacles encountered in designing antiepileptic drug trials. French JA Epilepsy Res Suppl; 1993; 10():81-9. PubMed ID: 8251107 [No Abstract] [Full Text] [Related]
8. Patient recruitment and compliance issues in clinical trials. Cramer JA Epilepsy Res Suppl; 1993; 10():211-22. PubMed ID: 8251099 [No Abstract] [Full Text] [Related]
9. [The roles and responsibilities of the pharmaceutical industry]. Dejgaard A; Thomsen MK Ugeskr Laeger; 2003 Apr; 165(16):1676-9. PubMed ID: 12756829 [TBL] [Abstract][Full Text] [Related]
10. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry. Dorfman HL; Reig LP Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876 [No Abstract] [Full Text] [Related]
12. Fostering the relationship between the clinical research associate and the drug study coordinator. Brodie MA Epilepsy Res Suppl; 1993; 10():233-7. PubMed ID: 8251101 [No Abstract] [Full Text] [Related]
13. Role of the Institutional Review Board in clinical trials. Skolnick BE Epilepsy Res Suppl; 1993; 10():193-200. PubMed ID: 8251097 [No Abstract] [Full Text] [Related]
14. Large clinical trials in epilepsy: funding by the NIH versus pharmaceutical industry. Privitera M Epilepsy Res; 2006 Jan; 68(1):52-6. PubMed ID: 16377139 [TBL] [Abstract][Full Text] [Related]
15. The role of the pharmacist in investigational AED trials. Graves NM Epilepsy Res Suppl; 1993; 10():201-9. PubMed ID: 8251098 [No Abstract] [Full Text] [Related]
16. Industry-sponsored pharmaceutical trials and research ethics boards: are they cloaked in too much secrecy? Ferris LE CMAJ; 2002 May; 166(10):1279-80. PubMed ID: 12041844 [No Abstract] [Full Text] [Related]
17. Evaluation of clinical efficacy in antiepileptic drug trials. Schmidt D Epilepsy Res Suppl; 1991; 3():69-77. PubMed ID: 1777084 [No Abstract] [Full Text] [Related]
18. [Legal liability in clinical trials from the legal-pharmaceutical viewpoint]. Amon F Z Arztl Fortbild (Jena); 1995 Nov; 89(6):638-41. PubMed ID: 8588437 [TBL] [Abstract][Full Text] [Related]
19. Dealing with drug dependency: a commentary on ILAE's partnership with the pharmaceutical industry. Avanzini G; Engel J Epilepsia; 2007 Oct; 48(10):1821-4. PubMed ID: 17683507 [No Abstract] [Full Text] [Related]
20. [Openness in the cooperation between physicians and private corporations]. Jørgensen J; Djurhuus JC Ugeskr Laeger; 2003 Apr; 165(16):1642-5. PubMed ID: 12756817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]